Market closedNon-fractional
Akili, Inc. Common Stock/AKLI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Akili, Inc. Common Stock
Akili Inc is a digital medicine company pioneering the development of cognitive treatments through game-changing technologies.
Ticker
AKLI
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Technology
Headquarters
Boston, United States
Employees
68
Website
www.akiliinteractive.com
AKLI Metrics
BasicAdvanced
$34M
Market cap
-
P/E ratio
-$0.62
EPS
1.72
Beta
-
Dividend rate
Price and volume
Market cap
$34M
Beta
1.72
Financial strength
Current ratio
5.797
Quick ratio
5.646
Long term debt to equity
10.584
Total debt to equity
27.073
Interest coverage (TTM)
-25.69%
Management effectiveness
Return on assets (TTM)
-36.62%
Return on equity (TTM)
-68.06%
Valuation
Price to revenue (TTM)
17.29
Price to book
0.67
Price to tangible book (TTM)
0.67
Price to free cash flow (TTM)
-0.69
Growth
Revenue change (TTM)
426.49%
Earnings per share change (TTM)
124.19%
What the Analysts think about AKLI
Analyst Ratings
Majority rating from 1 analysts.
AKLI Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$300K
-57.14%
Net income
-$9.7M
-12.61%
Profit margin
-3,233.33%
103.90%
AKLI Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.17
-$0.16
-$0.18
-
-$0.12
Expected
-$0.22
-$0.20
-$0.19
-$0.21
-$0.14
Surprise
-21.11%
-20.99%
-5.26%
-
-14.29%
AKLI News
AllArticlesVideos
![Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game](https://cdn.snapi.dev/images/v1/h/n/press20-2485550.jpg)
Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game
Business Wire·3 weeks ago
![AKILI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akili, Inc. - AKLI](https://cdn.snapi.dev/images/v1/v/q/press9-2480494.jpg)
AKILI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akili, Inc. - AKLI
PRNewsWire·3 weeks ago
![SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, CALT, SGE on Behalf of Shareholders](https://cdn.snapi.dev/images/v1/e/j/press3-2468648.jpg)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, CALT, SGE on Behalf of Shareholders
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Akili, Inc. Common Stock stock?
Akili, Inc. Common Stock (AKLI) has a market cap of $34M as of July 06, 2024.
What is the P/E ratio for Akili, Inc. Common Stock stock?
The price to earnings (P/E) ratio for Akili, Inc. Common Stock (AKLI) stock is 0 as of July 06, 2024.
Does Akili, Inc. Common Stock stock pay dividends?
No, Akili, Inc. Common Stock (AKLI) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Akili, Inc. Common Stock dividend payment date?
Akili, Inc. Common Stock (AKLI) stock does not pay dividends to its shareholders.
What is the beta indicator for Akili, Inc. Common Stock?
Akili, Inc. Common Stock (AKLI) has a beta rating of 1.72. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
![Buy or sell Akili, Inc. Common Stock stock](/_next/image?url=%2Fresources%2Fimages%2Fpromo_phone.png&w=256&q=75)
Buy or sell Akili, Inc. Common Stock stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.